» Articles » PMID: 35958566

TGFβ Limits Myc-dependent TCR-induced Metabolic Reprogramming in CD8 T Cells

Overview
Journal Front Immunol
Date 2022 Aug 12
PMID 35958566
Authors
Affiliations
Soon will be listed here.
Abstract

T cell activation is dependent upon the integration of antigenic, co-stimulatory and cytokine-derived signals and the availability and acquisition of nutrients from the environment. Furthermore, T cell activation is accompanied by reprogramming of cellular metabolism to provide the energy and building blocks for proliferation, differentiation and effector function. Transforming growth factor β (TGFβ) has pleiotropic effects on T cell populations, having both an essential role in the maintenance of immune tolerance but also context-dependent pro-inflammatory functions. We set out to define the mechanisms underpinning the suppressive effects of TGFβ on mouse CD8 T cell activation. RNA-sequencing analysis of TCR-stimulated T cells determined that Myc-regulated genes were highly enriched within gene sets downregulated by TGFβ. Functional analysis demonstrated that TGFβ impeded TCR-induced upregulation of amino acid transporter expression, amino acid uptake and protein synthesis. Furthermore, TCR-induced upregulation of Myc-dependent glycolytic metabolism was substantially inhibited by TGFβ treatment with minimal effects on mitochondrial respiration. Thus, our data suggest that inhibition of Myc-dependent metabolic reprogramming represents a major mechanism underpinning the suppressive effects of TGFβ on CD8 T cell activation.

Citing Articles

Immunometabolism of CD8 T cell differentiation in cancer.

Shi H, Chen S, Chi H Trends Cancer. 2024; 10(7):610-626.

PMID: 38693002 PMC: 11342304. DOI: 10.1016/j.trecan.2024.03.010.


Regulation of T Cell Activation and Metabolism by Transforming Growth Factor-Beta.

Salmond R Biology (Basel). 2023; 12(2).

PMID: 36829573 PMC: 9953227. DOI: 10.3390/biology12020297.


Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.

Schirrmacher V, Van Gool S, Stuecker W Int J Mol Sci. 2022; 23(21).

PMID: 36361831 PMC: 9655431. DOI: 10.3390/ijms232113050.

References
1.
Chapman N, Chi H . mTOR Links Environmental Signals to T Cell Fate Decisions. Front Immunol. 2015; 5:686. PMC: 4299512. DOI: 10.3389/fimmu.2014.00686. View

2.
Frederick J, Liberati N, Waddell D, Shi Y, Wang X . Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol. 2004; 24(6):2546-59. PMC: 355825. DOI: 10.1128/MCB.24.6.2546-2559.2004. View

3.
Flavell R, Sanjabi S, Wrzesinski S, Licona-Limon P . The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010; 10(8):554-67. PMC: 3885992. DOI: 10.1038/nri2808. View

4.
Marchingo J, Sinclair L, Howden A, Cantrell D . Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation. Elife. 2020; 9. PMC: 7056270. DOI: 10.7554/eLife.53725. View

5.
Sinclair L, Rolf J, Emslie E, Shi Y, Taylor P, Cantrell D . Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol. 2013; 14(5):500-8. PMC: 3672957. DOI: 10.1038/ni.2556. View